Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Environ Toxicol ; 27(6): 351-63, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22566245

RESUMEN

Earlier, we proposed that the ability of folic acid and vitamin B12 to preserve systemic and mitochondrial function after short-term exposure to arsenic may prevent further progression to more permanent injury and pathological changes leading to cell death. To elucidate its mechanism, the present study examined the antiapoptotic efficacy of folic acid and vitamin B12 against short-term arsenic exposure-induced hepatic mitochondria oxidative stress and dysfunction. Sixteen to eighteen weeks old male albino rats weighing 140-150 × g were divided into five groups: Control (A), Arsenic-treated (B), Arsenic + folic acid (C), Arsenic +vitamin B12 (D), and Arsenic + folic acid + vitamin B12 (E). Data generated indicated that folic acid and vitamin B12 separately or in combination can give significant protection against alterations in oxidative stress and apoptotic marker parameters and downstream changes in mitochondria, namely pro-oxidative (NO, TBARS, OH⁻) and antioxidative defense (SOD, CAT, GSH) markers, iNOS protein expression, mitochondrial swelling, cytochrome c oxidase and Ca²âº-ATPase activity, Ca²âº content, caspase-3 activity. Additionally, results of hepatic cell DNA fragmentation, arsenic load of blood, hepatic tissue and urine, and histological observations, all strongly support that both these supplements have efficacy in preventing apoptotic changes and cellular damage. As the mechanisms of actions of both of these supplements are methylation related, a combined application was more effective. Results further reveal new molecular targets through which folic acid and vitamin B12 separately or in combination work to alleviate one critical component of arsenic-induced liver injury: mitochondria dysfunction.


Asunto(s)
Intoxicación por Arsénico/tratamiento farmacológico , Arsénico/toxicidad , Suplementos Dietéticos , Ácido Fólico/farmacología , Vitamina B 12/farmacología , Complejo Vitamínico B/farmacología , Animales , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/patología , Masculino , Mitocondrias/metabolismo , Estrés Oxidativo/efectos de los fármacos , Distribución Aleatoria , Ratas
2.
Phytother Res ; 23(9): 1287-94, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19277962

RESUMEN

The protective action of aqueous black tea extract (BTE) against ovariectomy-induced oxidative stress of mononuclear cells and its associated progression of bone loss was demonstrated in this study. Eighteen female adult 6-month-old Wistar albino rats were divided into three groups: sham-control (A), bilaterally ovariectomized (B) and bilaterally ovariectomized + BTE supplemented (C). Studies included the measurement of oxidative (nitric oxide, lipid peroxidation) and antioxidative (superoxide dismutase, catalase) markers, inflammatory cytokines (IL-6, TNF-alpha), osteoclast differentiation factor (RANKL) and bone resorption markers (tartrate-resistant acid phosphatase and hydroxyproline). Also quantitative histomorphometry and histological studies were undertaken. The bone breaking force was measured. The results indicate that BTE was effective in preserving and restoring skeletal health by reducing the number of active osteoclasts. Such changes with BTE supplementation were steadily linked with the reduced oxidative stress of mononuclear cells, serum levels of bone resorbing cytokines, osteoclast differentiation factor and resorption markers. The results of the bone breaking force, histological and histomorphometric analyses further supported the hypothesis. This study suggests that BTE has both protective and restorative actions against ovariectomy-induced mononuclear cell oxidative stress and associated bone loss.


Asunto(s)
Resorción Ósea/prevención & control , Camellia sinensis/química , Leucocitos Mononucleares/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Fosfatasa Ácida/metabolismo , Animales , Huesos/patología , Catalasa/metabolismo , Células Cultivadas , Citocinas/sangre , Femenino , Hidroxiprolina/orina , Isoenzimas/metabolismo , Leucocitos Mononucleares/metabolismo , Peroxidación de Lípido , Óxido Nítrico/metabolismo , Ovariectomía , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo , Fosfatasa Ácida Tartratorresistente , Té/química
3.
Environ Toxicol ; 24(4): 377-87, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18825727

RESUMEN

The effect of folic acid and folic acid + vitamin B(12) supplementation upon short-term arsenic-induced systemic and pancreatic islet cell mitochondria oxidative stress was investigated in male rats. Arsenic trioxide was administered orally at a dose of 3 mg kg body weight(-1) day(-1) for 30 days, and folic acid and vitamin B(12) were administered at a dose of 36 and 0.63 microg kg body weight(-1) day(-1), respectively, for 30 days. Compared to control, arsenic-treated group showed a significant increase in the levels of systemic oxidative markers, malondialdehyde (MDA), nitric oxide (NO), and hydroxyl radical (OH(-)) formation, which were found decreased significantly after supplementation either with folic acid or a combination of folic acid + vitamin B(12). Similar supplementations were found effective against arsenic-induced oxidative marker changes (MDA, NO, and OH(-)) in pancreatic islet cell mitochondria. Also, low activities of antioxidant defense enzymes such as superoxide dismutase and catalase, and level of antioxidant glutathione, all could regain significantly on supplementations both against systemic and islet cell mitochondria oxidative stress. Results of agarose-gel electrophoresis of DNA from lymphocytes and islet cells of arsenic-exposed rats showed DNA smearing, which could be reduced with simultaneous administration either with folic acid or a combination of folic acid + vitamin B(12). Significantly, similar supplementations were found effective in increasing the urinary clearance of arsenic. Together, these results indicate that folic acid and vitamin B(12) may be effective to reduce the arsenic-induced damage at molecular target level.


Asunto(s)
Antioxidantes/farmacología , Intoxicación por Arsénico/prevención & control , Ácido Fólico/farmacología , Óxidos/toxicidad , Vitamina B 12/farmacología , Animales , Trióxido de Arsénico , Arsenicales/metabolismo , Biomarcadores/metabolismo , Catalasa/metabolismo , Quimioprevención , Daño del ADN/efectos de los fármacos , Ácido Deshidroascórbico/análogos & derivados , Ácido Deshidroascórbico/metabolismo , Quimioterapia Combinada , Glutatión/metabolismo , Islotes Pancreáticos/metabolismo , Linfocitos/metabolismo , Masculino , Mitocondrias/efectos de los fármacos , Nitritos/metabolismo , Estrés Oxidativo/efectos de los fármacos , Óxidos/metabolismo , Ratas , Superóxido Dismutasa/metabolismo
4.
Life Sci ; 77(24): 3049-57, 2005 Oct 28.
Artículo en Inglés | MEDLINE | ID: mdl-15996685

RESUMEN

The adverse side effects of currently available anti-osteoporotic agents warrant the search for compounds with less toxic effects. In this study, we assessed the phytoestrogenic potentiality of whole aqueous extract of black tea (BTE) in a bilaterally oophorectomized rat model (2.5%, 1 ml/100 g body weight/day for 28 days). Although the supplementation was given for 28 days but, sign of revival of copulation period (estrous stage) from non-receptive diestrous stage was first noticed after 21 days of BTE supplementation in bilaterally oophorectomized rats. This was accompanied by a significant increase in serum estradiol level. To test whether this increase in serum estradiol level could have an influence upon the oophorectomy-induced damage of bone, we assessed marker parameters of bone resorption and osteoclastic activity (tartrate-resistant acid phosphatase), collagen degradation (urinary hydroxyproline), bone loss (bone ash mineral content) and bone breaking strength (bone density). Results indicated that increase in serum estradiol level after BTE supplementation could significantly diminish oophorectomy-induced decaying changes in bone. This study proposes that aqueous BTE may be assessed as a phytoestrogenic compound for prevention against estrogen deficiency-related osteoporotic damages.


Asunto(s)
Densidad Ósea/efectos de los fármacos , Resorción Ósea/prevención & control , Huesos/patología , Ovariectomía , , Fosfatasa Ácida/metabolismo , Animales , Calcio/metabolismo , Colágeno/metabolismo , Suplementos Dietéticos , Estradiol/sangre , Femenino , Hidroxiprolina/orina , Ratas , Tartratos/farmacología
5.
J Osteoporos ; 2013: 760586, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23984184

RESUMEN

The present study was undertaken to find out the ability of black tea extract (BTE) as a suitable alternative of adjunct for calcium supplementation in treating an ovariectomized rat model of early osteoporosis. Female Wistar rats weighing 140-150 g were divided into four groups consisting of six animals in each group: (A) sham-operated control; (B) bilaterally ovariectomized; (C) bilaterally ovariectomized + BTE; (D) bilaterally ovariectomized + 17 ß -estradiol. Results suggest that BTE could promote intestinal absorption of calcium significantly (P < 0.01 for duodenum and ileum; and P < 0.05 for jejunum). This was found associated with enhanced activities of two relevant intestinal mucosal enzymes alkaline phosphatase (P < 0.01 for duodenum, jejunum, and ileum) and Ca(2+) activated ATPase (P < 0.01 for duodenum, jejunum, and ileum). Such BTE-mediated promotion of calcium absorption was coupled with increase in serum estrogen titer (P < 0.01) and recovery of all urinary, bone, and serum osteoporotic marker parameters, including bone histological features. Serum parathyroid hormone level, however, was not altered in these animals (P > 0.05). A comparative study with 17 ß -estradiol, a well-known adjunct for calcium supplementation, indicated that efficacy of BTE in maintaining skeletal health is close to that of 17 ß -estradiol. This study suggests that simultaneous use of BTE is promising as a prospective candidate for adjunctive therapies for calcium supplementation in the early stage of menopausal bone changes.

6.
Nat Prod Res ; 26(6): 500-9, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-21711176

RESUMEN

This study examined the efficacy of hydroalcoholic extract of dried clove buds, which is rich in phenolic compounds namely eugenol and eugenol derivatives (precursors of flavones, isoflavones and flavonoids), on different primary and secondary osteoporotic marker changes in an ovariectomised (OVX) rat model of osteoporosis. Female Wistar rats were randomly divided into three groups: sham-operated control (A), OVX (B) and OVX plus 50% hydroalcoholic extract of dried clove buds for 4 weeks (C). Results indicated that, compared to control, serum alkaline phosphatase (AP; 48.25%, p < 0.01), serum tartrate-resistant acid phosphatase (TRAP; 63.48%, p < 0.01), urinary calcium (14.70%, p < 0.01), urinary phosphate (50.30%, p < 0.01) and urinary creatinine (122.44%, p < 0.01) were significantly altered in OVX rats. All these altered responses were significantly restored (AP: 27.53%, p < 0.01; TRAP: 33.51%, p < 0.01; calcium: 53.15%, p < 0.01; phosphate: 27.49%, p < 0.01; creatinine: 46.40%, p < 0.01) by supplementation with hydroalcoholic extract of dried clove buds. Results of bone density, bone mineral content, bone tensile strength and histological analysis also showed similar trend of results, which supported initial observations of this study. It is proposed that hydroalcoholic extract of dried clove buds has bone-preserving efficacy against hypogonadal osteoporosis.


Asunto(s)
Aceite de Clavo/uso terapéutico , Osteoporosis/prevención & control , Fosfatasa Ácida/sangre , Fosfatasa Alcalina/sangre , Animales , Densidad Ósea/efectos de los fármacos , Calcio/deficiencia , Calcio/orina , Aceite de Clavo/farmacología , Creatinina/orina , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Eugenol/análogos & derivados , Eugenol/farmacología , Eugenol/uso terapéutico , Femenino , Isoenzimas/sangre , Ovariectomía , Fosfatos/orina , Ratas , Ratas Wistar , Fosfatasa Ácida Tartratorresistente , Resistencia a la Tracción/efectos de los fármacos , Tibia/efectos de los fármacos
7.
Environ Toxicol Pharmacol ; 31(1): 107-18, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21787675

RESUMEN

The present study was aimed to test the hypothesis that inorganic phosphate may reduce arsenic toxicity by decreasing its intestinal transference. Co-administration of inorganic phosphate (6.56 M) and arsenic (6.07 mM) in the intestinal loops of rats, in situ, caused significant reduction of arsenic transference. Short-term arsenic exposure (3mg/kg body weight/day for 30 days) caused liver damage evidenced by activities of liver enzymes and necroinflammatory changes. These effects of arsenic were coupled with enhanced mitochondrial swelling, inhibition of cytochrome c oxidase, Ca(2+)-ATPase, a decrease in mitochondrial calcium content, changes in indices of hepatic mitochondrial oxidative stress and iNOS expression. Arsenic also increased hepatic caspase 3 activity and DNA fragmentation. All these apoptosis-related molecular changes caused by arsenic could be alleviated by supplementation with inorganic phosphate, which likely suggests a protective role of phosphate against arsenic-induced hepatotoxic changes.


Asunto(s)
Arsénico/antagonistas & inhibidores , Arsénico/toxicidad , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/patología , Fosfatos/uso terapéutico , Fósforo Dietético/farmacología , Venenos/toxicidad , Animales , Intoxicación por Arsénico/metabolismo , Caspasa 3/metabolismo , Catalasa/metabolismo , Fragmentación del ADN/efectos de los fármacos , Suplementos Dietéticos , Radical Hidroxilo/metabolismo , Mucosa Intestinal/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Hígado/patología , Masculino , Membranas Mitocondriales/efectos de los fármacos , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa de Tipo II/metabolismo , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo
8.
Phytother Res ; 20(5): 408-15, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16619371

RESUMEN

The present study was undertaken to examine the effects of an oil extract of garlic on the in vivo intestinal transference of calcium, and also to verify its role in maintaining the bone mineral content and bone tensile strength in an ovariectomized rat model of osteoporosis. The results suggest that, in this experimental model, oil extract of garlic promotes intestinal transference of calcium by modulating the activities of both intestinal alkaline phosphatase and Ca(2+) activated ATPase. Also the observed low bone mineral content and low bone tensile strength in these rats were significantly restored by garlic oil supplementation. Further, garlic oil supplementation was able to revive partially the bilateral ovariectomy-induced decrease in the serum estrogen titer. The serum parathyroid hormone level, however, was found unaltered in these rats. The garlic oil supplemented partial recovery in serum estrogen titer in bilaterally ovariectomized rat was found to be persistently associated with enhanced calcium transference and better preservation of bone mineral content. The results of this study propose that the phytoestrogenic efficacy of an oil extract of garlic prevents ovarian hormone deficiency induced bone mineral loss possibly by promoting intestinal transference of calcium through the partial revival of the serum estrogen titer.


Asunto(s)
Densidad Ósea/efectos de los fármacos , ATPasas Transportadoras de Calcio/metabolismo , Ajo , Osteoporosis Posmenopáusica/tratamiento farmacológico , Fitoterapia , Aceites de Plantas/farmacología , Fosfatasa Alcalina/sangre , Animales , Modelos Animales de Enfermedad , Estradiol/sangre , Femenino , Humanos , Mucosa Intestinal/metabolismo , Osteoporosis Posmenopáusica/patología , Ovariectomía , Hormona Paratiroidea/sangre , Aceites de Plantas/administración & dosificación , Aceites de Plantas/uso terapéutico , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA